🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

322 results for “Hospital Authority, Hong Kong” Clear

  1. CAR T-cell therapy

    Hospital Authority, Hong Kong

    Lymphoblastic Leukemia, Acute, Childhood

    phase 1 mab active

    1 trial

  2. Cordyceps cicadae extract

    Hospital Authority, Hong Kong

    Myopia

    phase 1 mab completed

    1 trial

  3. Digoxin

    Hospital Authority, Hong Kong

    Healthy

    phase 1 small molecule completed

    1 trial

  4. Drugs administration

    Hospital Authority, Hong Kong

    Rotator Cuff Tears of the Shoulder

    phase 1 small molecule active

    1 trial

  5. Extraluminal use of Univent bronchial Blocker

    Hospital Authority, Hong Kong

    Therapeutic Procedural Complication

    phase 1 other completed

    1 trial

  6. Fospropofol disodium

    Hospital Authority, Hong Kong

    Drug Safety

    phase 1 small molecule completed

    1 trial

  7. GCPGC, Neulasta, Placebo

    Hospital Authority, Hong Kong

    Healthy

    phase 1 small molecule completed

    1 trial

  8. HBV mRNA vaccine

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  9. INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg

    Hospital Authority, Hong Kong

    COVID-19 Pandemic

    phase 1 mab active

    1 trial

  10. Implantation

    Hospital Authority, Hong Kong

    Bone Loss

    phase 1 other active

    1 trial

  11. Intercerebral implantation of allogenic CD34+ stem cell

    Hospital Authority, Hong Kong

    Ischemic Stroke

    phase 1 other active

    1 trial

  12. Interleukin, NK cells

    Hospital Authority, Hong Kong

    Metastatic Nasopharyngeal

    phase 1 small molecule completed

    1 trial

  13. Larotrectinib

    Hospital Authority, Hong Kong

    High Grade Glioma

    phase 1 small molecule active

    1 trial

  14. MTL-CEBPA

    Hospital Authority, Hong Kong

    Advanced Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  15. Motion analysis of patients

    Hospital Authority, Hong Kong

    Leg Length Discrepancy

    phase 1 other completed

    1 trial

  16. Neoadjuvant chemotherapy

    Hospital Authority, Hong Kong

    Squamous Cell Carcinoma of Oral Cavity

    phase 1 small molecule completed

    1 trial

  17. OPB-51602

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma

    phase 1 small molecule terminated

    1 trial

  18. Oxidized regenerated cellulose(ORC)

    Hospital Authority, Hong Kong

    Thyroidectomy

    phase 1 small molecule completed

    1 trial

  19. PRG-1801

    Hospital Authority, Hong Kong

    Immune Thrombocytopenia

    phase 1 small molecule active

    1 trial

  20. Paclitaxel

    Hospital Authority, Hong Kong

    Ovarian Cancer

    phase 1 small molecule active

    1 trial

  21. Silodosin

    Hospital Authority, Hong Kong

    Benign Prostatic Hyperplasia

    phase 1 small molecule completed

    1 trial

  22. Tissue Plasminogen Activator (tPA)

    Hospital Authority, Hong Kong

    Peritoneal Dialysis

    phase 1 small molecule terminated

    1 trial

  23. UTAA91 injection

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis (RA)

    phase 1 mab active

    1 trial

  24. Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg

    Hospital Authority, Hong Kong

    COVID-19 Pandemic

    phase 1 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources